Source:http://linkedlifedata.com/resource/pubmed/id/11348720
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
25-26
|
pubmed:dateCreated |
2001-5-11
|
pubmed:abstractText |
The immunogenicity of two vector-based vaccines, either given alone or in a prime-boost regimen, was investigated. Cynomolgus macaques were immunised with modified vaccinia virus Ankara (MVA) expressing simian immunodeficiency virus (SIV)macJ5 env, gag-pol, nef, rev, and tat genes (MVA-SIVmac) or primed with a Semliki forest virus (SFV) vaccine expressing the same genes (SFV-SIVmac) and boosted with MVA-SIVmac. Generally, antibody responses, T-cell proliferative responses and cytotoxic T-cell responses remained low or undetectable in vaccinees receiving MVA-SIVmac or SFV-SIVmac alone. In contrast, monkeys who first received SFV-SIVmac twice and then were boosted with MVA-SIVmac showed increased antibody responses as well as high T-cell proliferative responses. Three of these vaccinees had cytotoxic T-lymphocytes directed against three or four of the gene products. No evidence of protection was seen against an intrarectal heterologous SIVsm challenge given 3 months after the last immunisation. The study demonstrates a prime-boost strategy that efficiently induces both humoral and cellular immune responses.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/AIDS Vaccines,
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Viral,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Viral,
http://linkedlifedata.com/resource/pubmed/chemical/SAIDS Vaccines,
http://linkedlifedata.com/resource/pubmed/chemical/Vaccines, Synthetic
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0264-410X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
14
|
pubmed:volume |
19
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
3526-36
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11348720-AIDS Vaccines,
pubmed-meshheading:11348720-Animals,
pubmed-meshheading:11348720-Antibodies, Viral,
pubmed-meshheading:11348720-Antibody Specificity,
pubmed-meshheading:11348720-Genetic Vectors,
pubmed-meshheading:11348720-Immunity, Cellular,
pubmed-meshheading:11348720-Immunization, Secondary,
pubmed-meshheading:11348720-Lymphocyte Activation,
pubmed-meshheading:11348720-Lymphocyte Count,
pubmed-meshheading:11348720-Macaca fascicularis,
pubmed-meshheading:11348720-RNA, Viral,
pubmed-meshheading:11348720-SAIDS Vaccines,
pubmed-meshheading:11348720-Semliki forest virus,
pubmed-meshheading:11348720-Simian immunodeficiency virus,
pubmed-meshheading:11348720-T-Lymphocytes,
pubmed-meshheading:11348720-Vaccines, Synthetic,
pubmed-meshheading:11348720-Vaccinia virus
|
pubmed:year |
2001
|
pubmed:articleTitle |
Enhanced simian immunodeficiency virus-specific immune responses in macaques induced by priming with recombinant Semliki Forest virus and boosting with modified vaccinia virus Ankara.
|
pubmed:affiliation |
Swedish Institute for Infectious Disease Control, SE-171 82, Solna, Sweden. charlotta.nilsson@smi.ki.se
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|